Contrary to this, a larger clinical study that examined the relationship between PTHrP production and bone metastasis in patients with operable breast cancer revealed that patients with PTHrP positive tumours had significantly improved survival rate with less metastases to bone than patients with PTHrP-negative tumours [5], [9]. This evidence concerns the gene PTHLH and breast cancer.